Paradigm Shift Therapeutics
BioTech/Drugs - North Bethesda, MD, US
Paradigm Shift Therapeutics Employees
Paradigm Shift Therapeutics Senior Management
Paradigm Shift Therapeutics Details
Paradigm Shift Therapeutics, LLC (PSTx) was founded with a mission to develop transformational and affordable cancer therapies using a lean proof of concept approach. PSTx was launched in January 2014 by Teresa Burgess, Ph.D. and Kate Farrell, Ph.D. with an ongoing collaboration with Dr. David Roberts at the NCI focused on developing novel CD47-targeting inhibitors-a target with the potential to radically change cancer treatment. Thomas Miller, Ph.D. joined PSTx as a full partner in September 2014. The goal of our team is to develop inhibitors of CD47 that can be translated into clinical practice for treatment of patients with cancer.
Paradigm Shift Therapeutics Technologies
Load Balancers
Varnish
CMS
Wix
Hosting
Google Cloud Hosting
Other
Mobile Friendly